Andrew Hill

7PUBLICATIONS
20CO-AUTHORS
Epidemiological modellingEnvironmental epidemiologyGene and molecular therapyTaxation lawBehavioural epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 12, 2025
A model-based comparison of dose reduction strategies for fixed-dose dolutegravir-containing regimens.

Laura Dickinson, Laura Else, Willem D F Venter

|Sep 30, 2024
Results From Systematic Review and Meta-analysis of the Efficacy and Safety of Two-drug Versus Three-drug (Tenofovir/Lamivudine/Dolutegravir; TLD) Regimens for HIV Treatment.

Cassandra Fairhead, Jacob Levi, Nydile Ramesh

|Sep 03, 2024
Lenacapavir to prevent HIV infection: current prices versus estimated costs of production.

Andrew Hill, Jacob Levi, Cassandra Fairhead

|Jul 19, 2024
Low CD4 counts predict excessive weight gains during first-line treatment for HIV.

Andrew Hill, Tamara Tovar Sanchez, Eric Delaporte

|Jul 10, 2024
Lower Prevalence Countries Outside of South-Eastern Africa Now Have the Fastest Growing HIV Epidemic.

Toby Pepperrell, Andrew Hill, Samuel Cross

Pageof 2